Abattis Bioceuticals Corp. (OTC Pink: ATTBF) (CSE: ATT) Climbs 37% After Announcing Acquisition of Pro Natura BV, A Netherlands-Based Nutraceutical Company

Abattis Bioceuticals Corp. (OTC Pink: ATTBF) (CSE: ATT) operates as a Canadian medical cannabis company that has a cultivation site on Gabriola Island, impressive portfolio of 140 genetic cannabis strains, and a strong fertilizer and nutrient assets. U.S.-listed shares of the Canadian cannabis company are rallying 36.52%, through early trading on Wednesday, April 3, 2019. Over the past month, Abattis…

Read More

Signature Devices, Inc. Releases 2018 Strong Financial Results With an Increase of 165% in Revenue From 2017

Signature Devices, Inc.

IRVINE, CA, April 01, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Signature Devices, Inc. (OTC PINK: SDVI), and its subsidiary Nano 101, today announced the release of its annual financials and report for 2018. Included in the report are financials that incorporate Q4 data from the Nano 101 Technology acquisition and detailed view of the Nano 101 business model and…

Read More